FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (FPIIOVH)
发明人:
Laura Soucek,Marie-Eve Beaulieu
申请号：
US16433438
公开号：
US20190382468A1
申请日:
2019.06.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to a Myc dominant negative mutant, called Omomyc, for use in medicine and for use in the prevention and/or treatment of cancer. The invention also refers to a fusion protein comprising Omomyc and pharmaceutical composition thereof and their use in medicine and, in particular, for treatment of cancer.
